Synapse - Works

Results (5712)

NCI Awardee Skills Development Consortium (NASDC): Applicant profiles

Meeting Abstract

Verschraegen, C. F.; Hashibe, M.; O'Connell, A.; Neill, U.; Rodriguez, R.; Pirl, W. F.; Gray, T.; Yusufov, M.; Hexner, E.; Mankoff, D. A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT)

Meeting Abstract

De Lima, M. J. G.; Kebriaei, P.; Lanza, F.; Cho, C.; Giralt, S.; Popradi, G.; Hemmer, M. T.; Zhang, X.; Shah, R.; Welch, V. L.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

First-in-human study of TAS3681, an oral androgen receptor (AR) antagonist with AR and AR splice variant (AR-SV) downregulation activity, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) refractory to abiraterone (ABI) and/or enzalutamide (ENZ) and chemotherapy (CT)

Meeting Abstract

De Bono, J. S.; Cook, N.; Yu, E. Y.; Lara, P. N.; Wang, J. S.; Yamasaki, Y.; Yamamiya, I.; Gao, P.; Calleja, E. M.; Rathkopf, D. E.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Updated outcomes with axicabtagene ciloleucel (axi-cel) retreatment (reTx) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) in ZUMA-5

Meeting Abstract

Chavez, J. C.; Jacobson, C. A.; Sehgal, A.; Neelapu, S. S.; Maloney, D. G.; Salles, G. A.; William, B. M.; Yang, Y.; Goyal, L.; Chou, J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Late immune-related adverse events with immune checkpoint inhibitors

Meeting Abstract

Ip, A.; Wang, S.; Cheruku, D.; Krishnamurthy, K.; Weber, M.; Sinclaire, B.; Paleoudis, E. G.; Alaoui, A.; Lev-Ari, S.; Serzan, M. T.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors

Meeting Abstract

Schram, A. M.; Kamath, S. D.; El-Khoueiry, A. B.; Borad, M. J.; Mody, K.; Mahipal, A.; Goyal, L.; Sahai, V.; Schmidt-Kittler, O.; Shen, J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Preliminary clinical and biologic results of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab, in advanced solid tumors (KEYNOTE A36)

Meeting Abstract

Park, H.; Bendell, J. C.; Messersmith, W. A.; Rasco, D. W.; De Bono, J. S.; Strickler, J. H.; Zhou, L.; Carter, L. L.; Bruey, J. M.; Li, J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial

Meeting Abstract

Balar, A. V.; Milowsky, M. I.; O'Donnell, P. H.; Alva, A. S.; Kollmeier, M.; Rose, T. L.; Pitroda, S.; Kaffenberger, S. D.; Rosenberg, J. E.; Francese, K.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

First-in-human phase I study of the bifunctional EGFR/TGF beta fusion protein BCA101 in patients with EGFR-driven advanced solid cancers

Meeting Abstract

Janku, F.; Hanna, G. J.; Carvajal, R. D.; Paik, P. K.; Hernando-Calvo, A.; Gillison, M. L.; Fu, S.; Wheler, J. J.; Bohr, D.; Reiners, R.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

ALK inhibitors for treatment of adult-onset neuroblastoma

Meeting Abstract

Stiefel, J.; Kushner, B. H.; Basu, E. M.; Roberts, S. S.; Modak, S.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save